Wednesday, September 14, 2022 1:29:40 PM
Recall that Koos and his world famous cancer doc, Dr. Kesari, were unsuccessful in getting the IND for DCellVax because the pre-clinical data was lacking. Hence why the IND was never approved to start P1 trials.
I am going to bet that we'll see a similar issue with what he is doing now.
Btw, most of the gain from yesterday is gone.
That shouldn't be surprising to anyone. And I was wrong. I thought we'd see some gain today and the sell off tomorrow. Looks like most traders know not to hold onto this for more than a few trading hours.
FACTS are stubborn things
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM